Chronic Prostatitis Model
Chronic Prostatitis Model - Related Videos
06:48
An Orthotopic Murine Model of Human Prostate Cancer Metastasis
0 Views •
Cited by 30 •
2013
This orthotopic model of human prostate cancer allows for quantification of tumor size, circulating tumor cells, and formation of distinct metastasis to the lung. As cells must escape the primary organ, enter the blood stream, and implant into a secondary site, this model effectively recapitulates the scenario in humans.
07:01
Pre-clinical Orthotopic Murine Model of Human Prostate Cancer
0 Views •
Cited by 17 •
2016
Prostate cancer is the second most common cause of cancer-related deaths in the United States. An orthotopic cancer model provides a useful approach to understand the biology of prostate cancer and to evaluate the efficacy of therapeutic regimens. This protocol describes detailed steps necessary to establish an orthotopic prostate cancer mouse model.
06:46
Measurement of Tactile Allodynia in a Murine Model of Bacterial Prostatitis
0 Views •
Cited by 23 •
2013
Infection of the prostate may be a contributing factor in mediating pelvic pain in chronic prostatitis. We describe the procedure for preparation of standardized bacterial inoculum, instillation of bacteria into the urethra of male mice and methodology for measuring tactile allodynia in mice over time.
09:49
Assessment of Perigenital Sensitivity and Prostatic Mast Cell Activation in a Mouse Model of Neonatal Maternal Separation
0 Views •
Cited by 25 •
2015
We are measuring perigenital mechanical sensitivity and mast cell activation in the prostate of male C57BL/6 mice that underwent an early life stress paradigm – neonatal maternal separation, in order to induce a preclinical model of chronic prostatitis/chronic pelvic pain syndrome.
04:40
Modeling Prostate Cancer in Genetically-engineered Mouse Models: A CRISPR/Cas9-mediated Localized Gene Editing Technique in Mouse Anterior Prostate Lobe Cells
0 Views •
2023
This video describes a method for editing specific genes in prostate gland cells using an adenovirus-based delivery system. The approach allows for orthotopic and localized alteration of gene expression utilizing CRISPR technology to develop novel mouse models for prostate cancer.
FAQs
Their value comes from examining connected disease domains within one experimental system. Investigators can relate prostatic immune responses and tissue changes to pain signaling and urinary dysfunction, rather than treating inflammation as an isolated endpoint. This integrated view helps clarify how local prostate pathology may contribute to persistent pelvic symptoms and supports a more complete assessment of disease mechanisms.
These strategies provide different experimental routes for establishing or maintaining prostatic inflammation. A biological process, chemical process, or other approach may offer a distinct way to investigate immune responses, tissue alterations, pain signaling, or urinary effects. Selecting among them allows researchers to match the experimental system to the mechanism or outcome they want to examine.
Persistent inflammation is important because the condition has complex and sometimes poorly defined causes, while symptoms can continue over time. A model that maintains chronic changes gives researchers a controlled setting for examining relationships among inflammation, tissue responses, pelvic pain, and urinary dysfunction. This supports investigation of mechanisms that may be missed when observations focus only on short-term effects.
These outcomes represent different consequences of the same experimental condition and may reveal complementary aspects of disease biology. Immune findings describe inflammatory responses, tissue assessments show local structural effects, and pain or urinary measures capture functional consequences. Considering them together helps determine whether an experimental intervention changes only inflammation or also improves related pelvic and urinary features.
A typical study establishes or maintains prostatic inflammation through a selected experimental process, evaluates relevant biological and functional outcomes, and then compares those findings with the effects of an intervention or control condition. The sequence creates a controlled platform for linking the experimental process to immune responses, tissue changes, pain signaling, urinary dysfunction, or treatment-related outcomes.
The findings can show how experimental inflammation affects prostate tissue, immune activity, pain-related signaling, and urinary function. Together, these measurements help researchers characterize disease mechanisms and determine whether a tested strategy influences local inflammation, associated symptoms, or both. The resulting profile also provides a basis for comparing different therapeutic approaches within a controlled research setting.
Researchers use these systems when they need a controlled platform for examining strategies directed at persistent prostatic inflammation and related symptoms. The models can support assessment of anti-inflammatory, analgesic, antimicrobial, and other therapeutic approaches. Results may contribute to treatment development by showing how an intervention affects inflammatory processes, pain-related features, urinary dysfunction, or several outcomes together.